Overview A Comparative Bioavailability Study of Lisinopril Tablets, 40 mg - Effect of Food Study Status: Completed Trial end date: 1999-10-01 Target enrollment: Participant gender: Summary The purpose of this study is to compare the bioavailability of Par Lisinopril 40 mg Tablets and IPR Pharmaceuticals, Inc. Zestril (R). Phase: Phase 1 Details Lead Sponsor: Par Pharmaceutical, Inc.Collaborator: PharmaKinetics Laboratories Inc.Treatments: Lisinopril